MSLN and cancer: Mesothelin is a glycoprotein abundantly expressed in lung, ovarian, colon, pancreatic and mesothelioma cancer and due to its distinctive expression pattern and key role in enhancing cancer dissemination, aggressiveness and drug insensitivity, MSLN is an intriguing marker for cancer therapy.